Skip to menu Skip to content Skip to footer

2015

Journal Article

Altered expression of metabolic proteins and adipokines in patients with amyotrophic lateral sclerosis

Ngo, S. T., Steyn, F. J., Huang, L., Mantovani, S., Pfluger, C. M. M., Woodruff, T. M., O'Sullivan, J. D., Henderson, R. D. and McCombe, P. A. (2015). Altered expression of metabolic proteins and adipokines in patients with amyotrophic lateral sclerosis. Journal of the Neurological Sciences, 357 (1-2), 22-27. doi: 10.1016/j.jns.2015.06.053

Altered expression of metabolic proteins and adipokines in patients with amyotrophic lateral sclerosis

2015

Journal Article

Circulating brain derived neurotrophic factor (BDNF) and frequency of BDNF positive T cells in peripheral blood in human ischemic stroke: effect on outcome

Chan, Adeline, Yan, Jun, Csurhes, Peter, Greer, Judith and McCombe, Pamela (2015). Circulating brain derived neurotrophic factor (BDNF) and frequency of BDNF positive T cells in peripheral blood in human ischemic stroke: effect on outcome. Journal of Neuroimmunology, 286, 42-47. doi: 10.1016/j.jneuroim.2015.06.013

Circulating brain derived neurotrophic factor (BDNF) and frequency of BDNF positive T cells in peripheral blood in human ischemic stroke: effect on outcome

2015

Journal Article

When does ALS start? A novel SOD-1 p.Gly142Arg mutation causing motor neurone disease with prominent premorbid cramps and spasms

Ioannides, Z. A., Henderson, R. D., Robertson, T., Davis, M. and McCombe, P. A. (2015). When does ALS start? A novel SOD-1 p.Gly142Arg mutation causing motor neurone disease with prominent premorbid cramps and spasms. Journal of Neurology, Neurosurgery and Psychiatry, 87 (9), 1031-1032. doi: 10.1136/jnnp-2015-311582

When does ALS start? A novel SOD-1 p.Gly142Arg mutation causing motor neurone disease with prominent premorbid cramps and spasms

2015

Conference Publication

Effect of relapse phenotype on the accumulation of disability in relapsing-remitting multiple sclerosis

Stewart, T., Jokubaitis, V., Spelman, T., Havrdova, E., Horakova, D., Trojano, M., Izquierdo, G., Girard, M., Duquette, P., Prat, A., Lugaresi, A., Grammond, P., Grand'Maison, F., Sola, P., Hupperts, R., Petersen, T., Pucci, E., Bergamaschi, R., Boz, C., Oreja-Guevara, C., Lechner-Scott, J., Alroughani, R., Ramo, C., Van Pesch, V., Fernandez-Bolanos, R., Iuliano, G., Rio, M. E., Granella, F., Slee, M. ... Kalincik, T. (2015). Effect of relapse phenotype on the accumulation of disability in relapsing-remitting multiple sclerosis. 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Oct 07-10, 2015. LONDON: SAGE PUBLICATIONS LTD.

Effect of relapse phenotype on the accumulation of disability in relapsing-remitting multiple sclerosis

2015

Conference Publication

Pregnancy outcomes in patients with active RRMS who received alemtuzumab in the clinical development program

Achiron, A., Chambers, C., Fox, E. J., Mc Combe, P., Otero, S., Margolin, D. H., Kasten, L. and Compston, D. A. S. (2015). Pregnancy outcomes in patients with active RRMS who received alemtuzumab in the clinical development program. 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Oct 07-10, 2015. LONDON: SAGE PUBLICATIONS LTD.

Pregnancy outcomes in patients with active RRMS who received alemtuzumab in the clinical development program

2015

Conference Publication

10-year progression predictors after first treatment initiation in a relapsing-remitting MS cohort

Jokubaitis, V. G., Spelman, T., Kalincik, T., Travaglini, D., Paolicelli, D., Duquette, P., Girard, M., Prat, A., Havrdova, E., Horakova, D., Izquierdo, G., Grammond, P., Pucci, E., Grand'Maison, F., Bergamaschi, R., Granella, F., Van Pesch, V., Hupperts, R., Iuliano, G., Spitaleri, D., Sola, P., Boz, C., Fernandez-Bolanos, R., Petersen, T., Verheul, F., Olascoaga, J., McCombe, P., Rozsa, C., Lechner-Scott, J. ... Trojano, M. (2015). 10-year progression predictors after first treatment initiation in a relapsing-remitting MS cohort. 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Oct 07-10, 2015. LONDON: SAGE PUBLICATIONS LTD.

10-year progression predictors after first treatment initiation in a relapsing-remitting MS cohort

2015

Conference Publication

Defining secondary progressive multiple sclerosis

Lorscheider, J., Buzzard, K., Jokubaitis, V., Spelman, T., Havrdova, E., Horakova, D., Trojano, M., Izquierdo, G., Girard, M., Duquette, P., Prat, A., Lugaresi, A., Grand'Maison, F., Grammond, P., Hupperts, R., Alroughani, R., Sola, P., Boz, C., Terzi, M., Pucci, E., Lechner-Scott, J., Bergamaschi, R., Oreja-Guevara, C., Iuliano, G., Van Pesch, V., Bolanos, R. Fernandez, Granella, F., Rio, M. E., Ramo, C. ... Kalincik, T. (2015). Defining secondary progressive multiple sclerosis. 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Oct 07-10, 2015. LONDON: SAGE PUBLICATIONS LTD.

Defining secondary progressive multiple sclerosis

2015

Journal Article

A new era in the treatment of multiple sclerosis

Broadley, Simon A., Barnett, Michael H., Boggild, Mike, Brew, Bruce J., Butzkueven, Helmut, Heard, Robert, Hodgkinson, Suzanne, Kermode, Allan G., Lechner-Scott, Jeannette, Macdonell, Richard A. L., Marriott, Mark, Mason, Deborah F., Parratt, John, Reddel, Stephen W., Shaw, Cameron P., Slee, Mark, Spies, Judith M., Taylor, Bruce V., Carroll, William M., Kilpatrick, Trevor J., King, John, McCombe, Pamela A., Pollard, John D. and Willoughby, Ernest (2015). A new era in the treatment of multiple sclerosis. Medical Journal of Australia, 203 (3), 139-141e.1. doi: 10.5694/mja14.01218

A new era in the treatment of multiple sclerosis

2015

Journal Article

The frequencies of Killer immunoglobulin-like receptors and their HLA ligands in chronic inflammatory demyelinating polyradiculoneuropathy are similar to those in Guillian Barre syndrome but differ from those of controls, suggesting a role for NK cells in

Blum, Stefan, Csurhes, Peter and McCombe, Pamela (2015). The frequencies of Killer immunoglobulin-like receptors and their HLA ligands in chronic inflammatory demyelinating polyradiculoneuropathy are similar to those in Guillian Barre syndrome but differ from those of controls, suggesting a role for NK cells in. Journal of Neuroimmunology, 285, 53-56. doi: 10.1016/j.jneuroim.2015.05.017

The frequencies of Killer immunoglobulin-like receptors and their HLA ligands in chronic inflammatory demyelinating polyradiculoneuropathy are similar to those in Guillian Barre syndrome but differ from those of controls, suggesting a role for NK cells in

2015

Journal Article

Clinical features and impact of myasthenia gravis disease in Australian patients

Blum, Stefan, Lee, David, Gillis, David, McEniery, David F., Reddel, Stephen and McCombe, Pamela (2015). Clinical features and impact of myasthenia gravis disease in Australian patients. Journal of Clinical Neuroscience, 22 (7), 1164-1169. doi: 10.1016/j.jocn.2015.01.022

Clinical features and impact of myasthenia gravis disease in Australian patients

2015

Journal Article

Serial measurements of phosphorylated neurofilament-heavy in the serum of subjects with amyotrophic lateral sclerosis

McCombe, P. A., Pfluger, C., Singh, P., Lim, C. Y. H., Airey, C. and Henderson, R. D. (2015). Serial measurements of phosphorylated neurofilament-heavy in the serum of subjects with amyotrophic lateral sclerosis. Journal of the Neurological Sciences, 353 (1-2), 122-129. doi: 10.1016/j.jns.2015.04.032

Serial measurements of phosphorylated neurofilament-heavy in the serum of subjects with amyotrophic lateral sclerosis

2015

Journal Article

Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis

Kalincik, Tomas, Horakova, Dana, Spelman, Tim, Jokubaitis, Vilija, Trojano, Maria, Lugaresi, Alessandra, Izquierdo, Guillermo, Rozsa, Csilla, Grammond, Pierre, Alroughani, Raed, Duquette, Pierre, Girard, Marc, Pucci, Eugenio, Lechner-Scott, Jeannette, Slee, Mark, Fernandez-Bolanos, Ricardo, Grand'Maison, Francois, Hupperts, Raymond, Verheul, Freek, Hodgkinson, Suzanne, Oreja-Guevara, Celia, Spitaleri, Daniele, Barnett, Michael, Terzi, Murat, Bergamaschi, Roberto, McCombe, Pamela, Sanchez-Menoyo, Jose, Simo Magdolna, Csepany, Tunde ... and on behalf of the MSBase Study Group (2015). Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis. Annals of Neurology, 77 (3), 425-435. doi: 10.1002/ana.24339

Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis

2015

Conference Publication

Contribution of various relapse phenotypes to disability in multiple sclerosis

Kalincik, Tomas, Stewart, Tamasine, Jokubaitis, Vilija, Spelman, Tim, Lechner-Scott, Jeannette, Slee, Mark, Hodgkinson, Suzanne, McCombe, Pamela, Barnett, Michael, Vucic, Steve, Shuey, Neil, Shaw, Cameron and Butzkueven, Helmut (2015). Contribution of various relapse phenotypes to disability in multiple sclerosis. MS Research Australia Progress in MS Research Conference, Melbourne, Australia, Oct 29-30, 2015. London, United Kingdom: Sage Publications. doi: 10.1177/1352458515616527

Contribution of various relapse phenotypes to disability in multiple sclerosis

2015

Conference Publication

The missing brain glutamate transporters: what we missed and how this changes our understanding of the excitable brain

Pow, D., Lee, A., Klinkradt, S., Balcar, V. and McCombe, P. (2015). The missing brain glutamate transporters: what we missed and how this changes our understanding of the excitable brain. 25th Biennial Meeting of the International Society for Neurochemistry Jointly with the 13th Meeting of the Asian Pacific Society for Neurochemistry in Conjunction with the 35th Meeting of the Australasian Neuroscience Society, Cairns, QLD Australia Conference, 23-27 August 2015. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/jnc.13185

The missing brain glutamate transporters: what we missed and how this changes our understanding of the excitable brain

2015

Journal Article

Exposing asymmetric gray matter vulnerability in amyotrophic lateral sclerosis

Devine, Matthew S., Pannek, Kerstin, Coulthard, Alan, McCombe, Pamela A., Rose, Stephen E. and Henderson, Robert D. (2015). Exposing asymmetric gray matter vulnerability in amyotrophic lateral sclerosis. NeuroImage: Clinical, 7, 782-787. doi: 10.1016/j.nicl.2015.03.006

Exposing asymmetric gray matter vulnerability in amyotrophic lateral sclerosis

2015

Conference Publication

Pregnancy outcomes in the alemtuzumab MS clinical development program

McCombe, P., Achiron, A., Brinar, V., Margolin, D. H., Palmer, J., Oyuela, P. and Compston, D. A. S. (2015). Pregnancy outcomes in the alemtuzumab MS clinical development program. Pactrims Invited Lecture, Unknown, Unknown. London, United Kingdom: Sage Publications. doi: 10.1177/1352458514563659

Pregnancy outcomes in the alemtuzumab MS clinical development program

2015

Conference Publication

First-line injectable therapy and pregnancy protect against long-term disability accrual in patients with relapse-onset multiple sclerosis

Jokubaitis, Vilija, Spelman, Tim, Kalincik, Tomask, Lorscheider, Johannes, McCombe, Pamela, Lechner-Scott, Jeannette, Hodgkinson, Suzanne and Butzkueven, Helmut (2015). First-line injectable therapy and pregnancy protect against long-term disability accrual in patients with relapse-onset multiple sclerosis. MS Research Australia Progress in MS Research Conference, Melbourne, Australia, Oct 29-30, 2015. London, United Kingdom: Sage Publications. doi: 10.1177/1352458515616527

First-line injectable therapy and pregnancy protect against long-term disability accrual in patients with relapse-onset multiple sclerosis

2015

Journal Article

Female infertility and multiple sclerosis: is this an issue?

McCombe, Pamela A. and Stenager, Egon (2015). Female infertility and multiple sclerosis: is this an issue?. Multiple Sclerosis Journal, 21 (1), 5-7. doi: 10.1177/1352458514549406

Female infertility and multiple sclerosis: is this an issue?

2015

Book Chapter

High Caloric diets for amyotrophic lateral sclerosis

Ngo, Shyuan T., Steyn, Frederik J., McCombe, Pamela A. and Borges, Karin (2015). High Caloric diets for amyotrophic lateral sclerosis. Bioactive nutraceuticals and dietary supplements in neurological and brain disease: prevention and therapy. (pp. 355-361) edited by Ronald Ross Watson and Victor R. Preedy. London, United Kingdom: Academic Press. doi: 10.1016/B978-0-12-411462-3.00036-9

High Caloric diets for amyotrophic lateral sclerosis

2015

Conference Publication

Peripheral immune complement activation in neurodegenerative disease

Mantovani, S., Gordon, R., Ngo, S., Pfluger, C., O'Sullivan, J., Noakes, P., Henderson, R., McCombe, P. and Woodruff, T. (2015). Peripheral immune complement activation in neurodegenerative disease. 25th Biennial Meeting of the International-Society-for-Neurochemistry Jointly with the 13th Meeting of the Asian-Pacific-Society-for-Neurochemistry in Conjunction with the 35th Meeting of the Australasian-Neuroscience-Society, Cairns Australia, 23-27 August 2015. Chichester, West Sussex, United Kingdom: Wiley-Blackwell. doi: 10.1111/jnc.13188

Peripheral immune complement activation in neurodegenerative disease